ArticleProtein science : a publication of the Protein Society2026
Investigating operational stability and causes of cofactor release in fold type I amine transaminase.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigating operational stability and causes of cofactor release in fold type I amine transaminase.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Amine transaminases (ATAs) are pyridoxal phosphate (PLP) dependent biocatalysts frequently employed in chiral amine synthesis. Yields of ATA-catalyzed reactions often suffer from low enzyme operational stability due to weak interactions between the ATA and the aminated cofactor pyridoxamine phosphate (PMP), which can leak from the active site during catalytic cycles, destabilizing the ATA structure and causing inactivation. This study compared the operational stability of a single-substituted Chromobacterium violaceum ATA mutant (CvATA V124N) to its wildtype counterpart (CvATA) and Silicibacter pomeroyi ATA (SpATA) under various operating conditions. A kinetic model was developed to compare the PLP-binding and PMP-release rate constants of ATAs, and molecular dynamics (MD) simulations were performed to uncover the effects of the substitution on cofactor-ATA interactions. High amino donor concentration was found to selectively inhibit aminated product formation while promoting PMP release, and an amino donor-inhibition-induced PMP release mechanism via allosteric regulation was hypothesized based on the multimeric nature of ATA structures. MD simulation results predicted that the PMP release is likely initiated by solvent attack, and the reduced operational stability of the V124N mutant may be explained by the increased hydrophilicity introduced by the substitution. A hydrogen bond network near the SpATA active site, formed by a conserved set of hydrophilic amino acids, was identified via sequence analysis as a rare feature that potentially stabilizes the cofactor binding site structure and reduces solvent access to the solvent-free regions, which may explain the high cofactor affinity and operational stability of the ATA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.